- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Czech National Bank Boosts Stake in Johnson & Johnson
The central bank increased its holdings in the pharmaceutical giant by 3.9% in Q4 2025.
Mar. 28, 2026 at 8:07am
Got story updates? Submit your updates here. ›
According to a recent 13F filing with the SEC, the Czech National Bank raised its holdings in Johnson & Johnson (NYSE: JNJ) by 3.9% in the fourth quarter of 2025. The central bank now owns 635,294 shares of the company's stock, valued at approximately $131.5 million.
Why it matters
Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a strong presence in pharmaceuticals, medical devices, and consumer products. The Czech National Bank's increased stake in the company suggests confidence in J&J's long-term growth potential and ability to weather market volatility.
The details
The Czech National Bank's 13F filing shows it added 23,626 shares of Johnson & Johnson during the fourth quarter, bringing its total position to 635,294 shares. This represents approximately 0.9% of the central bank's overall investment portfolio. J&J's stock has seen strong performance in recent quarters, driven by the success of its pharmaceutical division and ongoing demand for its medical devices and consumer health products.
- The Czech National Bank disclosed its increased stake in Johnson & Johnson in a 13F filing with the SEC on March 28, 2026.
The players
Czech National Bank
The central bank of the Czech Republic, responsible for the country's monetary policy and financial stability.
Johnson & Johnson
A multinational pharmaceutical and medical devices company headquartered in New Brunswick, New Jersey.
The takeaway
The Czech National Bank's increased investment in Johnson & Johnson reflects the company's status as a blue-chip healthcare stock with a diversified portfolio and strong growth prospects. This move underscores the central bank's confidence in J&J's ability to deliver consistent returns for its shareholders.
